ReviewUrologie (Heidelberg, Germany)2026
[Current diagnostics and treatment of penile cancer].
Review in Urologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Penile cancer is a rare but relevant tumor entity. Due to the low case numbers in individual hospitals deviations from treatment standards and delayed treatment repeatedly occur. This is all the more serious as only an early and consistent treatment management can ensure a curative approach. For this reason, in several European countries penile cancer is only treated in a few special centers. This article provides a current overview of the epidemiology and etiology as well as diagnostic recommendations and treatment options for this malignant neoplasm. The early diagnosis is decisive for the subsequent approach. A consistent primary management with an organ-preserving complete resection of the primary tumor and all lymph nodes infested by the tumor whenever possible is a basic prerequisite for a curative treatment of penile cancer. In a metastatic situation a multimodal treatment concept is often necessary. A good psycho-oncological accompaniment of the patient and a consistent follow-up care also appear to be crucial.
Indexed as
Identifiers
41649557What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.